UBS Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.79M | Buy |
153,058
+47,725
| +45% | +$1.49M | ﹤0.01% | 3105 |
|
|
2025
Q1 | $3.53M | Buy |
105,333
+98,628
| +1,471% | +$3.31M | ﹤0.01% | 3252 |
|
|
2024
Q4 | $263K | Sell |
6,705
-6,585
| -50% | -$258K | ﹤0.01% | 5099 |
|
|
2024
Q3 | $523K | Buy |
13,290
+712
| +6% | +$28K | ﹤0.01% | 4064 |
|
|
2024
Q2 | $490K | Sell |
12,578
-23,668
| -65% | -$923K | ﹤0.01% | 3941 |
|
|
2024
Q1 | $1.56M | Buy |
36,246
+5,303
| +17% | +$228K | ﹤0.01% | 3192 |
|
|
2023
Q4 | $1.43M | Buy |
30,943
+25,061
| +426% | +$1.15M | ﹤0.01% | 3155 |
|
|
2023
Q3 | $201K | Buy |
5,882
+1,003
| +21% | +$34.3K | ﹤0.01% | 4279 |
|
|
2023
Q2 | $188K | Buy |
4,879
+265
| +6% | +$10.2K | ﹤0.01% | 4490 |
|
|
2023
Q1 | $165K | Sell |
4,614
-48
| -1% | -$1.72K | ﹤0.01% | 4486 |
|
|
2022
Q4 | $184K | Buy |
4,662
+1,236
| +36% | +$48.7K | ﹤0.01% | 4442 |
|
|
2022
Q3 | $123K | Buy |
3,426
+954
| +39% | +$34.3K | ﹤0.01% | 4486 |
|
|
2022
Q2 | $76K | Buy |
2,472
+1,249
| +102% | +$38.4K | ﹤0.01% | 4626 |
|
|
2022
Q1 | $38K | Sell |
1,223
-554
| -31% | -$17.2K | ﹤0.01% | 5740 |
|
|
2021
Q4 | $56K | Buy |
1,777
+755
| +74% | +$23.8K | ﹤0.01% | 5709 |
|
|
2021
Q3 | $16K | Buy |
1,022
+1
| +0.1% | +$16 | ﹤0.01% | 6297 |
|
|
2021
Q2 | $19K | Buy |
1,021
+21
| +2% | +$391 | ﹤0.01% | 6313 |
|
|
2021
Q1 | $18K | Sell |
1,000
-722
| -42% | -$13K | ﹤0.01% | 6454 |
|
|
2020
Q4 | $27K | Sell |
1,722
-264
| -13% | -$4.14K | ﹤0.01% | 5720 |
|
|
2020
Q3 | $22K | Sell |
1,986
-288
| -13% | -$3.19K | ﹤0.01% | 5386 |
|
|
2020
Q2 | $29K | Buy |
2,274
+1,642
| +260% | +$20.9K | ﹤0.01% | 5461 |
|
|
2020
Q1 | $7K | Sell |
632
-1,121
| -64% | -$12.4K | ﹤0.01% | 6246 |
|
|
2019
Q4 | $23K | Buy |
1,753
+522
| +42% | +$6.85K | ﹤0.01% | 5733 |
|
|
2019
Q3 | $11K | Sell |
1,231
-3,892
| -76% | -$34.8K | ﹤0.01% | 6152 |
|
|
2019
Q2 | $51K | Buy |
5,123
+2,123
| +71% | +$21.1K | ﹤0.01% | 5056 |
|
|
2019
Q1 | $30K | Buy |
3,000
+2,851
| +1,913% | +$28.5K | ﹤0.01% | 5128 |
|
|
2018
Q4 | $1K | Sell |
149
-705
| -83% | -$4.73K | ﹤0.01% | 6988 |
|
|
2018
Q3 | $11K | Sell |
854
-35
| -4% | -$451 | ﹤0.01% | 6203 |
|
|
2018
Q2 | $8K | Buy |
+889
| New | +$8K | ﹤0.01% | 6356 |
|
|
2017
Q3 | – | Sell |
-2,530
| Closed | -$8K | – | 6919 |
|
|
2017
Q2 | $8K | Buy |
+2,530
| New | +$8K | ﹤0.01% | 5980 |
|
|
2016
Q4 | – | Sell |
-617
| Closed | -$5K | – | 6917 |
|
|
2016
Q3 | $5K | Buy |
+617
| New | +$5K | ﹤0.01% | 6202 |
|
|
2016
Q2 | – | Sell |
-1,106
| Closed | -$8K | – | 6943 |
|
|
2016
Q1 | $8K | Sell |
1,106
-1,523
| -58% | -$11K | ﹤0.01% | 5947 |
|
|
2015
Q4 | $21K | Buy |
+2,629
| New | +$21K | ﹤0.01% | 5538 |
|
|
2015
Q3 | – | Sell |
-1,058
| Closed | -$12K | – | 6964 |
|
|
2015
Q2 | $12K | Buy |
1,058
+712
| +206% | +$8.08K | ﹤0.01% | 5868 |
|
|
2015
Q1 | $6K | Sell |
346
-26
| -7% | -$451 | ﹤0.01% | 6121 |
|
|
2014
Q4 | $7K | Buy |
+372
| New | +$7K | ﹤0.01% | 6196 |
|